Showing results (311-320 of 323) with videos related to

Sort By:
Pageof 33
BMC Cancer|March 30, 2019
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trialMaria Di Bartolomeo, Monica Niger, Federica Morano, et al.
European Journal of Cancer (Oxford, England : 1990)|July 23, 2019
A validated prognostic classifier for <sup>V600E</sup>BRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' studyFotios Loupakis, Rossana Intini, Chiara Cremolini, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|March 23, 2021
Personalized therapeutic strategies in HER2-driven gastric cancerStefano Ughetto, Cristina Migliore, Filippo Pietrantonio, et al.
Gut|October 30, 2025
Spatial profiling of patient-matched HER2 positive gastric cancer reveals resistance mechanisms to targeted therapyTaotao Sheng, Raghav Sundar, Supriya Srivastava, et al.
Nature Communications|April 25, 2026
Spatial predictors of response to chemo-immunotherapy in microsatellite stable metastatic colorectal cancerJoan Choo, Joseph J Zhao, Mai Chan Lau, et al.
Nature Medicine|May 27, 2020
Chemotherapy-induced ileal crypt apoptosis and the ileal microbiome shape immunosurveillance and prognosis of proximal colon cancerMaria Paula Roberti, Satoru Yonekura, Connie P M Duong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2021
Optimized EGFR Blockade Strategies in <i>EGFR</i> Addicted Gastroesophageal AdenocarcinomasSimona Corso, Filippo Pietrantonio, Maria Apicella, et al.
Gut|August 26, 2021
Epigenetic promoter alterations in GI tumour immune-editing and resistance to immune checkpoint inhibitionRaghav Sundar, Kie-Kyon Huang, Vikrant Kumar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 20, 2024
Circulating microRNA Analysis in a Prospective Co-clinical Trial Identifies MIR652-3p as a Response Biomarker and Driver of Regorafenib Resistance Mechanisms in Colorectal CancerSomaieh Hedayat, Luciano Cascione, David Cunningham, et al.
Cancer Research|October 6, 2019
A Comprehensive PDX Gastric Cancer Collection Captures Cancer Cell-Intrinsic Transcriptional MSI TraitsSimona Corso, Claudio Isella, Sara E Bellomo, et al.
Pageof 33